Skip to main content

Table 1 Demographic characteristics of patients with acute coronary syndrome in selected studies

From: Systematic review and meta-analysis of the prognostic impact of cancer among patients with acute coronary syndrome and/or percutaneous coronary intervention

 

Velders et al.

Ianaccone et al.

Wang et al.

Kurisu et al.

Rohrmann et al.

Gong et al.

Characteristics, n (%)

Cancer

n = 208

No cancer

n = 3215

Cancer

n = 858

No cancer

n = 13,773

Cancer

n = 263

No cancer

n = 2083

Cancer

n = 18

No cancer

n = 59

Cancer

n = 1981

No cancer

n = 1981

Cancer

n = 22,907

No cancer

n = 247,182

Age (years)

69.6 ± 11

62.8 ± 12.4

70.8 ± 10.3

62.8 ± 12.6

72.0 ± 10.7

63.3 ± 13.7

70.4 ± 8.1

68.8 ± 11.8

73.1 ± 11.6

73.1 ± 10.9

n/a

n/a

Men

141 (67.8)

2427 (75.5)

612 (71.3)

10,633 (77.2)

178 (67.7)

1480 (71.1)

13 (72.2)

44 (74.6)

1432 (72.3)

1443 (72.8)

13,996 (61.1)

153,747 (62.2)

Systemic hypertension

88 (42.7)

1135 (35.4)

558 (65)

7961 (57.8)

199 (75.7)

1429 (68.5)

11(61.1)

37 (62.7)

1309/1879 (69.7)

1313/1878 (69.9)

13,790 (60.2)

147,568 (59.7)

Diabetes mellitus

23 (11)

361 (11.2)

246 (28.7)

3237 (23.5)

44 (16.7)

381 (18.3)

7 (38.9)

25 (42.4)

439/1894 (23.2)

476/1890 (25.2)

6849 (29.9)

72,177 (29.2)

Hyperlipidemia

46 (22.4)

738 (23.1)

414 (48.2)

7327 (53.2)

186 (70.7)

1536 (73.7)

n/a

n/a

974/1704 (57.2)

1033/1737 (59.5)

8980 (39.2)

97,390 (39.4)

Active smoker

61 (31)

1487 (46.8)

n/a

n/a

169 (64.3)

1422 (68.3)

n/a

n/a

456/1728 (26.4)

494/1733 (28.5)

n/a

n/a

History of

 Myocardial infarction

35 (17)

335 (10.4)

132 (15.4)

1584 (11.5)

44 (16.7)

301 (14.5)

n/a

n/a

444/1981 (22.4)

404/1981 (20.4)

n/a

n/a

 PCI

21 (10.2)

267 (8.3)

125 (14.6)

1708 (12.4)

55 (20.9)

330 (15.8)

n/a

n/a

n/a

n/a

916 (4)

9640 (3.9)

 CABG

5 (2.4)

79 (2.5)

40 (4.7)

427 (3.1)

32 (12.2)

146 (7)

n/a

n/a

n/a

n/a

n/a

n/a

 Stroke

24 (11.7)

191 (5.9)

71 (8.3)

744 (5.4)

39 (14.8)

161 (7.7)

n/a

n/a

164/1981 (8.3)

153/1981 (7.7)

1558 (6.8)

15,573 (6.3)

 Anemia

53 (11.8)

152 (5.2)

n/a

n/a

n/a

n/a

9 (50)

4 (6.8)

312/807 (38.7)

192/777 (24.7)

4971 (21.7)

49,931 (20.2)

Clinical presentation

 STEMI

208 (100)

3215 (100)

440 (51.3)

8043 (58.4)

263 (100)

2083 (100)

n/a

n/a

1033/1981 (52.1)

987/1981 (49.8)

n/a

n/a

 NSTEMI

0

0

279 (32.5)

3912 (28.4)

0

0

n/a

n/a

n/a

n/a

n/a

n/a

 Unstable angina

0

0

139 (16.2)

1818 (13.2)

0

0

n/a

n/a

n/a

n/a

n/a

n/a

Number of diseased vessels

 1 vessel

87 (41.8)

1522 (47.4)

n/a

n/a

244 (92,8)

1959 (94)

9 (50)

35 (59.3)

n/a

n/a

n/a

n/a

 2 vessels

71 (34.1)

1005 (31.3)

n/a

n/a

19 (7.2)

119 (5.7)

7 (38.9)

17 (28.8)

n/a

n/a

n/a

n/a

 3 vessels

50 (24)

685 (21.3)

n/a

n/a

0

5 (0.2)

2 (11.1)

7 (11.9)

n/a

n/a

n/a

n/a

Procedure

 Stenting

192 (92.3)

3082 (95.9)

812 (94.6)

13,332 (96.8)

n/a

n/a

16 (88.9)

54 (91.5)

n/a

n/a

n/a

n/a

 Drug-eluting stent

124 (60.8)

2263 (70.8)

304 (35.4)

5523 (40.1)

110 (41.8)

1138 (54.6)

1 (5.6)

7 (11.9)

n/a

n/a

n/a

n/a

 Bare metal stent

67 (32.8)

812 (25.4)

508 (59.2)

7809 (56.7)

n/a

n/a

15 (83.3)

47 (79.7)

n/a

n/a

n/a

n/a

Treatments at discharge

 Beta-blockers

160 (84.2)

2812 (90.5)

640 (74.6)

11,198 (81.3)

n/a

n/a

2 (14.3)

27 (48.2)

1183/1960 (60.4)

1192/1957 (60.9)

7193 (31.4)

75,638 (30.6)

 ACE/ARBs

139 (73.2)

2220 (71.5)

605 (70.6)

10,344 (75.1)

n/a

n/a

6 (42.9)

43 (76.8)

995/1961 (50.7)

1038/1962 (52.9)

8705 (38)

90,963 (36.8)

 Statins

171 (90)

2897 (93.2)

780 (90.9)

12,878 (93.5)

n/a

n/a

8 (57.1)

41 (73.2)

1322/1958 (67.5)

1384/1965 (70.4)

5933 (25.9)

62,537 (25.3)

 Aspirin

187 (98.4)

3097 (99.3)

850 (99.1)

13,690 (99.4)

n/a

n/a

13 (92.9)

56 (100)

1829/1973 (92.7)

1858/1975 (94.1)

n/a

n/a

 P2Y12 inhibitors

186 (97.9)

3058 (98)

766 (89.3)

11,996 (87.1)

n/a

n/a

n/a

n/a

1380/1963 (70.3)

1465/1971 (74.3)

962 (4.2)

10,135 (4.1)

  1. ACE Angiotensin-Converting Enzyme; ARBs Angiotensin Receptor Blockers; CABG Coronary Artery Bypass Grafting; NSTEMI Non ST-Elevation Myocardial Infarction; PCI Percutaneous Coronary Intervention; STEMI ST-Elevation Myocardial Infarction; n/a not available